| NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older CM Alexander, PB Landsman, SM Teutsch, SM Haffner Diabetes 52 (5), 1210-1214, 2003 | 2005 | 2003 |
| Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian … SM Haffner, CM Alexander, TJ Cook, SJ Boccuzzi, TA Musliner, ... Archives of Internal Medicine 159 (22), 2661-2667, 1999 | 683 | 1999 |
| Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of … A CM Diabetes 52, 1210-1214, 2003 | 592 | 2003 |
| Continuous glucose monitoring and metrics for clinical trials: an international consensus statement T Battelino, CM Alexander, SA Amiel, G Arreaza-Rubin, RW Beck, ... The lancet Diabetes & endocrinology 11 (1), 42-57, 2023 | 388 | 2023 |
| Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease CA Sueta, M Chowdhury, SJ Boccuzzi, SC Smith Jr, CM Alexander, ... The American journal of cardiology 83 (9), 1303-1307, 1999 | 358 | 1999 |
| International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium–glucose cotransporter (SGLT) inhibitors T Danne, S Garg, AL Peters, JB Buse, C Mathieu, JH Pettus, ... Diabetes care 42 (6), 1147-1154, 2019 | 330 | 2019 |
| Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes CJ Girman, TD Kou, B Cai, CM Alexander, EA O’neill, ... Diabetes, Obesity and Metabolism 12 (9), 766-771, 2010 | 255 | 2010 |
| Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care MN Cook, CJ Girman, PP Stein, CM Alexander Diabetic medicine 24 (4), 350-358, 2007 | 235 | 2007 |
| Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes MN Cook, CJ Girman, PP Stein, CM Alexander, RR Holman Diabetes care 28 (5), 995-1000, 2005 | 224 | 2005 |
| Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease CM Alexander, PB Landsman, SM Teutsch The American journal of cardiology 86 (9), 897-902, 2000 | 201 | 2000 |
| Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting SJ Beaton, SS Nag, MJ Gunter, JM Gleeson, SS Sajjan, CM Alexander Diabetes care 27 (3), 694-698, 2004 | 173 | 2004 |
| Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events KA Foley, RJ Simpson, JR Crouse, TW Weiss, LE Markson, CM Alexander American Journal of Cardiology 92 (1), 79-81, 2003 | 156 | 2003 |
| Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non–ST-segment elevation myocardial infarction EM Mahoney, CT Jurkovitz, H Chu, ER Becker, S Culler, AS Kosinski, ... Jama 288 (15), 1851-1858, 2002 | 154 | 2002 |
| Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management … FA Guisasola, P Mavros, G Nocea, E Alemao, CM Alexander, D Yin Diabetes, obesity and metabolism 10, 8-15, 2008 | 139 | 2008 |
| Risk of acute renal failure in patients with type 2 diabetes mellitus CJ Girman, TD Kou, K Brodovicz, CM Alexander, EA O’Neill, S Engel, ... Diabetic Medicine 29 (5), 614-621, 2012 | 119 | 2012 |
| Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation WH Herman, S Shahinfar, GW Carides, EJ Dasbach, WC Gerth, ... Diabetes care 26 (3), 683-687, 2003 | 116 | 2003 |
| The influence of age and body mass index on the metabolic syndrome and its components CM Alexander, PB Landsman, SM Grundy Diabetes, Obesity and Metabolism 10 (3), 246-250, 2008 | 115 | 2008 |
| Lowering the criterion for impaired fasting glucose will not provide clinical benefit MB Davidson, PB Landsman, CM Alexander Diabetes Care 26 (12), 3329-3331, 2003 | 113 | 2003 |
| How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease? SA Grover, L Coupal, H Zowall, CM Alexander, TW Weiss, DRJ Gomes Diabetes Care 24 (1), 45-50, 2001 | 110 | 2001 |
| Economic and clinical impact of inpatient diabetic hypoglycemia SM Curkendall, JL Natoli, CM Alexander, BH Nathanson, T Haidar, ... Endocrine Practice 15 (4), 302-312, 2009 | 109 | 2009 |
